Answer
Tralokinumab monotherapy reduced itch compared with placebo as early as week 1 in both ECZTRA 1 and ECZTRA 2, measured by percentage change from baseline in Worst Daily Pruritus NRS.
Sources for this answer
- Adtralza 150 mg solution for injection in pre-filled syringeLeo Laboratories Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 9Document updated
Sources checked